Literature DB >> 2715167

Ester derivatives of the mammary-tumor-inhibiting antiestrogen 2,3-bis(2-fluoro-4-hydroxyphenyl)-2,3-dimethylbutane.

W Schwarz1, R W Hartmann, J Engel, M R Schneider, H Schönenberger.   

Abstract

The synthesis of the bisacetate (8), the bisdichloroacetate (9), the biscarbamate (10) and the bisphosphate (11) of the "partial" antiestrogen 2,3-bis(2-fluoro-4-hydroxyphenyl)-2,3-dimethylbutane (7) is described. In the case of 8-10 the introduction of ester functions slightly reduces the estrogen receptor affinity of 7. However, it was strongly diminished in 11. Compared with 7 the estrogenic potency of 8-11 is moderately increased. Compounds 8-11 cause a strong inhibition of the hormone-dependent MXT M3.2 mouse mammary tumor. Only 9 containing cytotoxic dichloroacetate groups shows a significantly better antitumor effect than 7.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2715167     DOI: 10.1007/BF00397917

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  22 in total

1.  Estrogen antagonisms: inhibition of estrone-induced uterine growth by testosterone propionate, progesterone and 17-ethyl-19-nortestosterone.

Authors:  R A EDGREN; D W CALHOUN
Journal:  Proc Soc Exp Biol Med       Date:  1957-03

2.  [Experimental basis of chemotherapy of cancer].

Authors:  H DRUCKREY
Journal:  Dtsch Med Wochenschr       Date:  1952-12-05       Impact factor: 0.628

3.  Some halogenated acetyl derivatives and their antitumor activity.

Authors:  A Sweeny; R H Goldfarb; T N Salmon; G Loewengart; R Fox; A Sicignano
Journal:  J Med Chem       Date:  1971-05       Impact factor: 7.446

4.  Evaluation of the antitumour activity of the non-steroidal antioestrogen monohydroxytamoxifen in the DMBA-induced rat mammary carcinoma model.

Authors:  V C Jordan; K E Allen
Journal:  Eur J Cancer       Date:  1980-02       Impact factor: 9.162

5.  Acetoxy-substituted 1,1,2-triphenylbut-1-enes with antiestrogenic and mammary tumor inhibiting properties.

Authors:  M R Schneider; H Ball; H Schönenberger
Journal:  J Med Chem       Date:  1985-12       Impact factor: 7.446

6.  Tamoxifen and metabolites in MCF7 cells: correlation between binding to estrogen receptor and inhibition of cell growth.

Authors:  E Coezy; J L Borgna; H Rochefort
Journal:  Cancer Res       Date:  1982-01       Impact factor: 12.701

7.  Serine derivative with antitumor activity.

Authors:  I LEVI; H BLONDAL; E LOZINSKI
Journal:  Science       Date:  1960-03-04       Impact factor: 47.728

8.  Anti-proliferative effects of 1,2-diphenylethane oestrogens and anti-oestrogens on human breast cancer cells.

Authors:  R W Hartmann; T Sinchai; G Kranzfelder
Journal:  J Cancer Res Clin Oncol       Date:  1985       Impact factor: 4.553

9.  Tumor growth-stimulating and inhibiting effects of antiestrogens on the DMBA-induced mammary carcinoma of the ovariectomized, diethylstilbestrol-treated SD rat. A study on the mechanism of action of antiestrogens.

Authors:  R W Hartmann
Journal:  Eur J Cancer Clin Oncol       Date:  1983-07

10.  Studies on the mammary tumor-inhibiting effects of diethylstilbestrol and its mono- and diphosphate.

Authors:  M R Schneider; E von Angerer; J Prekajac; W P Brade
Journal:  J Cancer Res Clin Oncol       Date:  1986       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.